Phase I/II study of novel oral fluoropyrimidine S-1 in combination with oxaliplatin (SOX) as first-line chemotherapy for metastatic colorectal cancer (mCRC)

被引：0
|
作者：
Tahara, M. [1 ]
Yamada, Y. [2 ]
Ohtsu, A. [1 ]
Shirao, K. [2 ]
Shimada, Y. [2 ]
Sasaki, Y. [3 ]
Yamamoto, W. [3 ]
Satoh, T. [4 ]
Okamoto, W. [4 ]
Tanigawara, Y. [5 ]
机构：
[1] Natl Canc Ctr Hosp E, Div Endoscopy & GI Oncol, Kashiwa, Chiba, Japan
[2] Natl Canc Ctr, Gastrointestinal Oncol Div, Tokyo, Japan
[3] Saitama Med Univ Int, Med Ctr, Dept Clin Oncol, Saitama, Japan
[4] Kinki Univ, Sch Med, Dept Med Oncol, Osaka, Japan
[5] Keio Univ Hosp, Dept Pharm, Tokyo, Japan
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)70989-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3061
引用
收藏
页码：254 / 254
页数：1
相关论文
共 50 条
  • [1] Phase I/II study of oxaliplatin (L-OHP) in combination with S-1 (SOX) as first-line therapy for metastatic colorectal cancer (MCRC)
    Yamada, Y.
    Ohtsu, A.
    Tahara, M.
    Doi, T.
    Kato, K.
    Hamaguchi, T.
    Shimada, Y.
    Shirao, K.
    EJC SUPPLEMENTS, 2006, 4 (12): : 142 - 143
  • [2] A phase I/II study of cetuximab (cet) in combination with S-1 and oxaliplatin (SOX) in first-line treatment for metastatic colorectal cancer (mCRC) (JACCRO CC-06).
    Tsuji, Akihito
    Sunakawa, Yu
    Denda, Tadamichi
    Takinishi, Yasutaka
    Kotaka, Masahito
    Tanioka, Hiroaki
    Shimada, Ken
    Kochi, Mitsugu
    Watanabe, Takanori
    Nakamura, Masato
    Ueda, Hiroto
    Inukai, Michio
    Masuishi, Toshiki
    Tani, Satoshi
    Negoro, Yuji
    Okuno, Tatsuya
    Takeuchi, Masahiro
    Ichikawa, Wataru
    Fujii, Masashi
    Nakajima, Toshifusa
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [3] Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancer
    Yamada, Y.
    Tahara, M.
    Miya, T.
    Satoh, T.
    Shirao, K.
    Shimada, Y.
    Ohtsu, A.
    Sasaki, Y.
    Tanigawara, Y.
    BRITISH JOURNAL OF CANCER, 2008, 98 (06) : 1034 - 1038
  • [4] Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancer
    Y Yamada
    M Tahara
    T Miya
    T Satoh
    K Shirao
    Y Shimada
    A Ohtsu
    Y Sasaki
    Y Tanigawara
    British Journal of Cancer, 2008, 98 : 1034 - 1038
  • [5] Phase I/II study of oral fluoropyrimidine S-1 plus oral Leucovorin as first-line treatment for metastatic colorectal cancer
    Yoshino, T.
    Koizumi, W.
    Yamaguchi, K.
    Miyata, Y.
    Kato, T.
    Toh, Y.
    Sawaki, A.
    Hyodo, I.
    Nishina, T.
    Boku, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] A phase II study of S-1 and oxaliplatin (SOx) combination chemotherapy as a first-line therapy for patients with advanced gastric cancer
    Sung Yong Oh
    Hyuk-Chan Kwon
    Sang-Ho Jeong
    Young-Tae Joo
    Young-Joon Lee
    Su hee Cho
    Myoung Hee Kang
    Se-il Go
    Gyeong-won Lee
    Hoon gu Kim
    Jung Hun Kang
    Investigational New Drugs, 2012, 30 : 350 - 356
  • [7] A phase II study of S-1 and oxaliplatin (SOx) combination chemotherapy as a first-line therapy for patients with advanced gastric cancer
    Oh, Sung Yong
    Kwon, Hyuk-Chan
    Jeong, Sang-Ho
    Joo, Young-Tae
    Lee, Young-Joon
    Cho, Su Hee
    Kang, Myoung Hee
    Go, Se-il
    Lee, Gyeong-won
    Kim, Hoon Gu
    Kang, Jung Hun
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (01) : 350 - 356
  • [8] The SOFT trial: a Phase III study of the dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine S-1 and oxaliplatin (SOX) plus bevacizumab as first-line chemotherapy for metastatic colorectal cancer
    Nakamura, Masato
    Yamada, Yasuhide
    Muro, Kei
    Takahashi, Keiichi
    Baba, Hideo
    Sasaki, Yasutsuna
    Komatsu, Yoshito
    Satoh, Taroh
    Mishima, Hideyuki
    Watanabe, Masahiko
    Sakata, Yuh
    Morita, Satoshi
    Shimada, Yasuhiro
    Sugihara, Kenichi
    FUTURE ONCOLOGY, 2015, 11 (10) : 1471 - 1478
  • [9] Efficacy of Combination Chemotherapy Using Oral Fluoropyrimidine S-1 with Oxaliplatin (SOX) against Colorectal Cancer In Vivo
    Nukatsuka, Mamoru
    Saito, Hitoshi
    Sakamoto, Kazuki
    Nakagawa, Fumio
    Uchida, Junji
    Kobunai, Takashi
    Shiraishi, Kazuyoshi
    Takechi, Teiji
    ANTICANCER RESEARCH, 2012, 32 (07) : 2807 - 2812
  • [10] CAPECITABINE AND OXALIPLATIN (XELOX) COMBINATION CHEMOTHERAPY AS FIRST-LINE TREATMENT FOR METASTATIC COLORECTAL CANCER-A PHASE II STUDY
    Tawfik, Hesham
    El-Deen, Hanan Gamal
    ANNALS OF ONCOLOGY, 2012, 23 : 98 - 98
12345